I Oswald. Show Affiliations »
Abstract
Mesh: See more » Aminobutyrates/pharmacologyAmphetamine/pharmacologyAnimalsAntidepressive Agents/pharmacologyBarbiturates/pharmacologyCaffeine/pharmacologyCatsClinical Trials as TopicDihydroxyphenylalanine/pharmacologyDreamsDrug UtilizationEthanol/pharmacologyHormones/pharmacologyHumansHydroxybutyrates/pharmacologyHypnotics and Sedatives/pharmacologyLysergic Acid Diethylamide/pharmacologyMethodsMonoamine Oxidase Inhibitors/pharmacologyMorphine/pharmacologyNicotine/pharmacologyParasympatholytics/pharmacologyParasympathomimetics/pharmacologyPhenytoin/pharmacologyRatsReserpine/pharmacologySleep/drug effectsSleep, REM/drug effectsTranquilizing Agents/pharmacologyTryptophan/pharmacology
Substances: See more » AminobutyratesAntidepressive AgentsBarbituratesHormonesHydroxybutyratesHypnotics and SedativesMonoamine Oxidase InhibitorsParasympatholyticsParasympathomimeticsTranquilizing AgentsCaffeineEthanolPhenytoinDihydroxyphenylalanineNicotineMorphineReserpineTryptophanLysergic Acid DiethylamideAmphetamine
Year: 1968 PMID: 4305226
Source DB: PubMed Journal: Pharmacol Rev ISSN: 0031-6997 Impact factor: 25.468